Could I Have SAD?
Take the quiz.
Could I Have OCD?
Take the quiz.
Healthcare
Professionals
Get important information
and facts about LUVOX CR.
Patient FAQs
How soon will I start to feel better?
Every person is different, so it's difficult to say how quickly LUVOX CR may begin helping you. It will depend on you as an individual and on your dosage. You and your doctor will partner to decide the right dosage for you. Since your medicine will be tailored just for you, it may need to be adjusted based on how you feel. Don't worry, though. This is common. Be patient and always take your LUVOX CR exactly as your doctor tells you to. If you are unsure about anything, ask questions.
How long should I take LUVOX CR?
The amount of time you need to take LUVOX CR will depend on your own needs. It is important to keep taking your medicine for as long as your doctor tells you to, even if you are feeling better. Do not stop taking your medicine unless your doctor tells you to.
How should LUVOX CR be taken?
LUVOX CR should be taken once-a-day at bedtime. It can be taken with or without food and is available in 100 mg and 150 mg capsules. Capsules should not be crushed or chewed.
Remember, your doctor has determined a specific dosing schedule of LUVOX CR just for you. It is important to take it exactly as instructed. LUVOX CR Capsules should be protected from high humidity and stored at 25°C (77°F); excursions permitted to 15°–30°C (59°–86°F) [see USP Controlled Room Temperature]. Avoid exposure to temperatures above 30°C (86°F).
What if I miss a day taking my medication?
If you miss a day or forget to take your medicine, don't worry. Just take the usual amount the next day. Do NOT take 2 doses to try to make up for the dose you missed.
Helpful tip
To help you remember to take LUVOX CR each day, make it part of your nightly bedtime routine.
Once-A-Day LUVOX CR® (fluvoxamine maleate) Extended-Release Capsules are indicated for the treatment of social anxiety disorder (SAD) and obsessive compulsive disorder (OCD).
Important Safety Information
CONTRAINDICATIONS
The use of alosetron, tizanidine, thioridazine, or pimozide with LUVOX CR Capsules is contraindicated. The use of MAO inhibitors in combination with LUVOX CR Capsules, or within 14 days of discontinuing treatment with LUVOX CR Capsules, is contraindicated (see WARNINGS and PRECAUTIONS). LUVOX CR Capsules are also contraindicated in patients with a history of hypersensitivity to fluvoxamine maleate or any of its excipients.
ADVERSE EVENTS
In clinical trials, the most commonly observed adverse events with an incidence of ≥5% and at least twice that of placebo were nausea, somnolence, asthenia, diarrhea, anorexia, tremor, and sweating. Overall, these side effects were mild to moderate in severity and transient in nature. Other common adverse events (≥5% and at least twice that of placebo) included abnormal ejaculation and anorgasmia.
Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of LUVOX CR® (fluvoxamine maleate) Extended-Release Capsules or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. LUVOX CR Capsules are not approved for use in pediatric patients. (See WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: Information for Patients, and PRECAUTIONS: Pediatric Use.)
Please see full prescribing information, including boxed warning, for LUVOX CR.
LUVOX CR is a registered trademark of Solvay Pharmaceuticals, Inc.
© 2008 Jazz Pharmaceuticals, Inc.
